Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)

Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Hamamoto, Koichi Fukino, Takahiko Tanigawa, Yoshiteru Sumiyoshi

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1274-1275
Number of pages2
JournalInvestigational new drugs
Volume30
Issue number3
DOIs
Publication statusPublished - 2012 Jun 1
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)

Cite this